nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—Auranofin—psoriatic arthritis	0.213	0.239	CbGbCtD
Enzalutamide—ALB—Prednisone—psoriatic arthritis	0.0678	0.0761	CbGbCtD
Enzalutamide—ABCB1—Methylprednisolone—psoriatic arthritis	0.0586	0.0657	CbGbCtD
Enzalutamide—CYP2C19—Prednisone—psoriatic arthritis	0.044	0.0493	CbGbCtD
Enzalutamide—CYP2B6—Dexamethasone—psoriatic arthritis	0.0432	0.0485	CbGbCtD
Enzalutamide—ABCB1—Betamethasone—psoriatic arthritis	0.0381	0.0427	CbGbCtD
Enzalutamide—ABCB1—Prednisolone—psoriatic arthritis	0.0376	0.0422	CbGbCtD
Enzalutamide—ABCB1—Prednisone—psoriatic arthritis	0.0355	0.0398	CbGbCtD
Enzalutamide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0351	0.0394	CbGbCtD
Enzalutamide—CYP3A5—Dexamethasone—psoriatic arthritis	0.034	0.0382	CbGbCtD
Enzalutamide—ALB—Methotrexate—psoriatic arthritis	0.034	0.0382	CbGbCtD
Enzalutamide—CYP2C8—Dexamethasone—psoriatic arthritis	0.0327	0.0367	CbGbCtD
Enzalutamide—CYP2C19—Dexamethasone—psoriatic arthritis	0.0275	0.0308	CbGbCtD
Enzalutamide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0266	0.0298	CbGbCtD
Enzalutamide—CYP2C9—Dexamethasone—psoriatic arthritis	0.0228	0.0256	CbGbCtD
Enzalutamide—CYP3A4—Betamethasone—psoriatic arthritis	0.0228	0.0256	CbGbCtD
Enzalutamide—CYP3A4—Prednisolone—psoriatic arthritis	0.0225	0.0253	CbGbCtD
Enzalutamide—ABCB1—Dexamethasone—psoriatic arthritis	0.0221	0.0249	CbGbCtD
Enzalutamide—CYP3A4—Prednisone—psoriatic arthritis	0.0213	0.0239	CbGbCtD
Enzalutamide—CYP2D6—Dexamethasone—psoriatic arthritis	0.0209	0.0234	CbGbCtD
Enzalutamide—ABCB1—Methotrexate—psoriatic arthritis	0.0178	0.02	CbGbCtD
Enzalutamide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0133	0.0149	CbGbCtD
Enzalutamide—Lung infection—Methotrexate—psoriatic arthritis	0.00461	0.0424	CcSEcCtD
Enzalutamide—Cognitive disorder—Methylprednisolone—psoriatic arthritis	0.00265	0.0243	CcSEcCtD
Enzalutamide—Cognitive disorder—Dexamethasone—psoriatic arthritis	0.00241	0.0221	CcSEcCtD
Enzalutamide—Cognitive disorder—Betamethasone—psoriatic arthritis	0.00241	0.0221	CcSEcCtD
Enzalutamide—Neutropenia—Auranofin—psoriatic arthritis	0.00229	0.0211	CcSEcCtD
Enzalutamide—Cognitive disorder—Prednisone—psoriatic arthritis	0.0021	0.0193	CcSEcCtD
Enzalutamide—Haematuria—Auranofin—psoriatic arthritis	0.00209	0.0192	CcSEcCtD
Enzalutamide—Fracture—Methylprednisolone—psoriatic arthritis	0.00197	0.0181	CcSEcCtD
Enzalutamide—Multiple fractures—Methylprednisolone—psoriatic arthritis	0.00197	0.0181	CcSEcCtD
Enzalutamide—Multiple fractures—Betamethasone—psoriatic arthritis	0.00179	0.0165	CcSEcCtD
Enzalutamide—Multiple fractures—Dexamethasone—psoriatic arthritis	0.00179	0.0165	CcSEcCtD
Enzalutamide—Fracture—Dexamethasone—psoriatic arthritis	0.00179	0.0165	CcSEcCtD
Enzalutamide—Fracture—Betamethasone—psoriatic arthritis	0.00179	0.0165	CcSEcCtD
Enzalutamide—Cognitive disorder—Methotrexate—psoriatic arthritis	0.00175	0.0161	CcSEcCtD
Enzalutamide—Fracture—Prednisone—psoriatic arthritis	0.00156	0.0143	CcSEcCtD
Enzalutamide—Multiple fractures—Prednisone—psoriatic arthritis	0.00156	0.0143	CcSEcCtD
Enzalutamide—Leukopenia—Auranofin—psoriatic arthritis	0.00153	0.0141	CcSEcCtD
Enzalutamide—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00137	0.0126	CcSEcCtD
Enzalutamide—Multiple fractures—Methotrexate—psoriatic arthritis	0.0013	0.012	CcSEcCtD
Enzalutamide—Fracture—Methotrexate—psoriatic arthritis	0.0013	0.012	CcSEcCtD
Enzalutamide—Memory impairment—Prednisone—psoriatic arthritis	0.00115	0.0106	CcSEcCtD
Enzalutamide—Pruritus—Auranofin—psoriatic arthritis	0.000987	0.00907	CcSEcCtD
Enzalutamide—Injury—Prednisolone—psoriatic arthritis	0.000985	0.00905	CcSEcCtD
Enzalutamide—Diarrhoea—Auranofin—psoriatic arthritis	0.000955	0.00878	CcSEcCtD
Enzalutamide—Injury—Triamcinolone—psoriatic arthritis	0.000906	0.00832	CcSEcCtD
Enzalutamide—Injury—Methylprednisolone—psoriatic arthritis	0.000904	0.00831	CcSEcCtD
Enzalutamide—Amnesia—Methylprednisolone—psoriatic arthritis	0.000884	0.00813	CcSEcCtD
Enzalutamide—Musculoskeletal stiffness—Methotrexate—psoriatic arthritis	0.000844	0.00776	CcSEcCtD
Enzalutamide—Dry skin—Prednisolone—psoriatic arthritis	0.00083	0.00763	CcSEcCtD
Enzalutamide—Injury—Dexamethasone—psoriatic arthritis	0.000822	0.00755	CcSEcCtD
Enzalutamide—Injury—Betamethasone—psoriatic arthritis	0.000822	0.00755	CcSEcCtD
Enzalutamide—Muscular weakness—Prednisolone—psoriatic arthritis	0.000798	0.00734	CcSEcCtD
Enzalutamide—Sepsis—Prednisone—psoriatic arthritis	0.000786	0.00723	CcSEcCtD
Enzalutamide—Muscular weakness—Triamcinolone—psoriatic arthritis	0.000734	0.00675	CcSEcCtD
Enzalutamide—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.000733	0.00673	CcSEcCtD
Enzalutamide—Injury—Prednisone—psoriatic arthritis	0.000716	0.00658	CcSEcCtD
Enzalutamide—Amnesia—Prednisone—psoriatic arthritis	0.0007	0.00644	CcSEcCtD
Enzalutamide—Dry skin—Betamethasone—psoriatic arthritis	0.000692	0.00636	CcSEcCtD
Enzalutamide—Dry skin—Dexamethasone—psoriatic arthritis	0.000692	0.00636	CcSEcCtD
Enzalutamide—Bronchitis—Triamcinolone—psoriatic arthritis	0.000692	0.00636	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.000669	0.00615	CcSEcCtD
Enzalutamide—Muscular weakness—Dexamethasone—psoriatic arthritis	0.000666	0.00612	CcSEcCtD
Enzalutamide—Muscular weakness—Betamethasone—psoriatic arthritis	0.000666	0.00612	CcSEcCtD
Enzalutamide—Sepsis—Methotrexate—psoriatic arthritis	0.000657	0.00604	CcSEcCtD
Enzalutamide—Infestation—Methylprednisolone—psoriatic arthritis	0.00064	0.00588	CcSEcCtD
Enzalutamide—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00064	0.00588	CcSEcCtD
Enzalutamide—Epistaxis—Triamcinolone—psoriatic arthritis	0.000605	0.00556	CcSEcCtD
Enzalutamide—Dry skin—Prednisone—psoriatic arthritis	0.000603	0.00554	CcSEcCtD
Enzalutamide—Muscular weakness—Prednisone—psoriatic arthritis	0.00058	0.00533	CcSEcCtD
Enzalutamide—Rhinitis—Triamcinolone—psoriatic arthritis	0.000577	0.00531	CcSEcCtD
Enzalutamide—Rhinitis—Methylprednisolone—psoriatic arthritis	0.000576	0.00529	CcSEcCtD
Enzalutamide—Pharyngitis—Triamcinolone—psoriatic arthritis	0.000572	0.00525	CcSEcCtD
Enzalutamide—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000565	0.00519	CcSEcCtD
Enzalutamide—Neutropenia—Prednisone—psoriatic arthritis	0.000532	0.00489	CcSEcCtD
Enzalutamide—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000521	0.00479	CcSEcCtD
Enzalutamide—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000503	0.00463	CcSEcCtD
Enzalutamide—Vertigo—Prednisolone—psoriatic arthritis	0.00049	0.0045	CcSEcCtD
Enzalutamide—Back pain—Triamcinolone—psoriatic arthritis	0.000485	0.00446	CcSEcCtD
Enzalutamide—Angiopathy—Betamethasone—psoriatic arthritis	0.000474	0.00436	CcSEcCtD
Enzalutamide—Angiopathy—Dexamethasone—psoriatic arthritis	0.000474	0.00436	CcSEcCtD
Enzalutamide—Convulsion—Prednisolone—psoriatic arthritis	0.000472	0.00434	CcSEcCtD
Enzalutamide—Hypertension—Prednisolone—psoriatic arthritis	0.000471	0.00433	CcSEcCtD
Enzalutamide—Vertigo—Triamcinolone—psoriatic arthritis	0.00045	0.00414	CcSEcCtD
Enzalutamide—Vertigo—Methylprednisolone—psoriatic arthritis	0.000449	0.00413	CcSEcCtD
Enzalutamide—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000447	0.00411	CcSEcCtD
Enzalutamide—Neutropenia—Methotrexate—psoriatic arthritis	0.000444	0.00408	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000442	0.00406	CcSEcCtD
Enzalutamide—Convulsion—Triamcinolone—psoriatic arthritis	0.000434	0.00399	CcSEcCtD
Enzalutamide—Convulsion—Methylprednisolone—psoriatic arthritis	0.000433	0.00398	CcSEcCtD
Enzalutamide—Hypertension—Triamcinolone—psoriatic arthritis	0.000433	0.00398	CcSEcCtD
Enzalutamide—Hypertension—Methylprednisolone—psoriatic arthritis	0.000432	0.00397	CcSEcCtD
Enzalutamide—Pneumonia—Methotrexate—psoriatic arthritis	0.000426	0.00392	CcSEcCtD
Enzalutamide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000426	0.00391	CcSEcCtD
Enzalutamide—Anxiety—Methylprednisolone—psoriatic arthritis	0.000424	0.0039	CcSEcCtD
Enzalutamide—Infestation—Methotrexate—psoriatic arthritis	0.000424	0.00389	CcSEcCtD
Enzalutamide—Infestation NOS—Methotrexate—psoriatic arthritis	0.000424	0.00389	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000423	0.00389	CcSEcCtD
Enzalutamide—Angiopathy—Prednisone—psoriatic arthritis	0.000413	0.00379	CcSEcCtD
Enzalutamide—Vertigo—Dexamethasone—psoriatic arthritis	0.000409	0.00376	CcSEcCtD
Enzalutamide—Vertigo—Betamethasone—psoriatic arthritis	0.000409	0.00376	CcSEcCtD
Enzalutamide—Infection—Triamcinolone—psoriatic arthritis	0.000407	0.00374	CcSEcCtD
Enzalutamide—Infection—Methylprednisolone—psoriatic arthritis	0.000406	0.00373	CcSEcCtD
Enzalutamide—Haematuria—Methotrexate—psoriatic arthritis	0.000404	0.00371	CcSEcCtD
Enzalutamide—Insomnia—Prednisolone—psoriatic arthritis	0.000402	0.0037	CcSEcCtD
Enzalutamide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0004	0.00368	CcSEcCtD
Enzalutamide—Epistaxis—Methotrexate—psoriatic arthritis	0.0004	0.00367	CcSEcCtD
Enzalutamide—Paraesthesia—Prednisolone—psoriatic arthritis	0.0004	0.00367	CcSEcCtD
Enzalutamide—Mental disorder—Prednisone—psoriatic arthritis	0.000399	0.00366	CcSEcCtD
Enzalutamide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000397	0.00364	CcSEcCtD
Enzalutamide—Convulsion—Dexamethasone—psoriatic arthritis	0.000394	0.00362	CcSEcCtD
Enzalutamide—Convulsion—Betamethasone—psoriatic arthritis	0.000394	0.00362	CcSEcCtD
Enzalutamide—Hypertension—Betamethasone—psoriatic arthritis	0.000393	0.00361	CcSEcCtD
Enzalutamide—Hypertension—Dexamethasone—psoriatic arthritis	0.000393	0.00361	CcSEcCtD
Enzalutamide—Anxiety—Dexamethasone—psoriatic arthritis	0.000386	0.00355	CcSEcCtD
Enzalutamide—Anxiety—Betamethasone—psoriatic arthritis	0.000386	0.00355	CcSEcCtD
Enzalutamide—Pharyngitis—Methotrexate—psoriatic arthritis	0.000377	0.00347	CcSEcCtD
Enzalutamide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000376	0.00345	CcSEcCtD
Enzalutamide—Urethral disorder—Methotrexate—psoriatic arthritis	0.000373	0.00343	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000373	0.00343	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000372	0.00342	CcSEcCtD
Enzalutamide—Insomnia—Triamcinolone—psoriatic arthritis	0.00037	0.0034	CcSEcCtD
Enzalutamide—Insomnia—Methylprednisolone—psoriatic arthritis	0.000369	0.00339	CcSEcCtD
Enzalutamide—Infection—Dexamethasone—psoriatic arthritis	0.000369	0.00339	CcSEcCtD
Enzalutamide—Infection—Betamethasone—psoriatic arthritis	0.000369	0.00339	CcSEcCtD
Enzalutamide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000367	0.00338	CcSEcCtD
Enzalutamide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000367	0.00337	CcSEcCtD
Enzalutamide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000364	0.00335	CcSEcCtD
Enzalutamide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000364	0.00335	CcSEcCtD
Enzalutamide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000364	0.00334	CcSEcCtD
Enzalutamide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000364	0.00334	CcSEcCtD
Enzalutamide—Vertigo—Prednisone—psoriatic arthritis	0.000356	0.00327	CcSEcCtD
Enzalutamide—Fatigue—Triamcinolone—psoriatic arthritis	0.000353	0.00324	CcSEcCtD
Enzalutamide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000352	0.00323	CcSEcCtD
Enzalutamide—Angiopathy—Methotrexate—psoriatic arthritis	0.000345	0.00317	CcSEcCtD
Enzalutamide—Convulsion—Prednisone—psoriatic arthritis	0.000343	0.00315	CcSEcCtD
Enzalutamide—Hypertension—Prednisone—psoriatic arthritis	0.000342	0.00314	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000338	0.00311	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000338	0.00311	CcSEcCtD
Enzalutamide—Arthralgia—Prednisone—psoriatic arthritis	0.000337	0.0031	CcSEcCtD
Enzalutamide—Anxiety—Prednisone—psoriatic arthritis	0.000336	0.00309	CcSEcCtD
Enzalutamide—Insomnia—Dexamethasone—psoriatic arthritis	0.000336	0.00309	CcSEcCtD
Enzalutamide—Insomnia—Betamethasone—psoriatic arthritis	0.000336	0.00309	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000335	0.00308	CcSEcCtD
Enzalutamide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000333	0.00306	CcSEcCtD
Enzalutamide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000333	0.00306	CcSEcCtD
Enzalutamide—Mental disorder—Methotrexate—psoriatic arthritis	0.000333	0.00306	CcSEcCtD
Enzalutamide—Infection—Prednisone—psoriatic arthritis	0.000321	0.00295	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000321	0.00295	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000321	0.00295	CcSEcCtD
Enzalutamide—Back pain—Methotrexate—psoriatic arthritis	0.00032	0.00294	CcSEcCtD
Enzalutamide—Fatigue—Betamethasone—psoriatic arthritis	0.00032	0.00294	CcSEcCtD
Enzalutamide—Fatigue—Dexamethasone—psoriatic arthritis	0.00032	0.00294	CcSEcCtD
Enzalutamide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000317	0.00291	CcSEcCtD
Enzalutamide—Skin disorder—Prednisone—psoriatic arthritis	0.000314	0.00289	CcSEcCtD
Enzalutamide—Vertigo—Methotrexate—psoriatic arthritis	0.000297	0.00273	CcSEcCtD
Enzalutamide—Leukopenia—Methotrexate—psoriatic arthritis	0.000296	0.00272	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000295	0.00271	CcSEcCtD
Enzalutamide—Dizziness—Prednisolone—psoriatic arthritis	0.000294	0.0027	CcSEcCtD
Enzalutamide—Asthenia—Triamcinolone—psoriatic arthritis	0.000294	0.0027	CcSEcCtD
Enzalutamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000293	0.00269	CcSEcCtD
Enzalutamide—Insomnia—Prednisone—psoriatic arthritis	0.000292	0.00269	CcSEcCtD
Enzalutamide—Paraesthesia—Prednisone—psoriatic arthritis	0.00029	0.00267	CcSEcCtD
Enzalutamide—Pruritus—Triamcinolone—psoriatic arthritis	0.000289	0.00266	CcSEcCtD
Enzalutamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000289	0.00265	CcSEcCtD
Enzalutamide—Convulsion—Methotrexate—psoriatic arthritis	0.000287	0.00264	CcSEcCtD
Enzalutamide—Arthralgia—Methotrexate—psoriatic arthritis	0.000282	0.00259	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00028	0.00257	CcSEcCtD
Enzalutamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000279	0.00257	CcSEcCtD
Enzalutamide—Fatigue—Prednisone—psoriatic arthritis	0.000279	0.00256	CcSEcCtD
Enzalutamide—Headache—Prednisolone—psoriatic arthritis	0.000279	0.00256	CcSEcCtD
Enzalutamide—Dizziness—Triamcinolone—psoriatic arthritis	0.000271	0.00249	CcSEcCtD
Enzalutamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.00027	0.00248	CcSEcCtD
Enzalutamide—Infection—Methotrexate—psoriatic arthritis	0.000268	0.00247	CcSEcCtD
Enzalutamide—Asthenia—Betamethasone—psoriatic arthritis	0.000266	0.00245	CcSEcCtD
Enzalutamide—Asthenia—Dexamethasone—psoriatic arthritis	0.000266	0.00245	CcSEcCtD
Enzalutamide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000265	0.00244	CcSEcCtD
Enzalutamide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000265	0.00243	CcSEcCtD
Enzalutamide—Pruritus—Betamethasone—psoriatic arthritis	0.000263	0.00241	CcSEcCtD
Enzalutamide—Pruritus—Dexamethasone—psoriatic arthritis	0.000263	0.00241	CcSEcCtD
Enzalutamide—Skin disorder—Methotrexate—psoriatic arthritis	0.000262	0.00241	CcSEcCtD
Enzalutamide—Headache—Triamcinolone—psoriatic arthritis	0.000256	0.00236	CcSEcCtD
Enzalutamide—Headache—Methylprednisolone—psoriatic arthritis	0.000256	0.00235	CcSEcCtD
Enzalutamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000254	0.00233	CcSEcCtD
Enzalutamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000254	0.00233	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000246	0.00226	CcSEcCtD
Enzalutamide—Dizziness—Betamethasone—psoriatic arthritis	0.000246	0.00226	CcSEcCtD
Enzalutamide—Dizziness—Dexamethasone—psoriatic arthritis	0.000246	0.00226	CcSEcCtD
Enzalutamide—Insomnia—Methotrexate—psoriatic arthritis	0.000244	0.00225	CcSEcCtD
Enzalutamide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000243	0.00223	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000233	0.00214	CcSEcCtD
Enzalutamide—Fatigue—Methotrexate—psoriatic arthritis	0.000233	0.00214	CcSEcCtD
Enzalutamide—Headache—Dexamethasone—psoriatic arthritis	0.000233	0.00214	CcSEcCtD
Enzalutamide—Headache—Betamethasone—psoriatic arthritis	0.000233	0.00214	CcSEcCtD
Enzalutamide—Asthenia—Prednisone—psoriatic arthritis	0.000232	0.00213	CcSEcCtD
Enzalutamide—Pruritus—Prednisone—psoriatic arthritis	0.000229	0.0021	CcSEcCtD
Enzalutamide—Diarrhoea—Prednisone—psoriatic arthritis	0.000221	0.00203	CcSEcCtD
Enzalutamide—Dizziness—Prednisone—psoriatic arthritis	0.000214	0.00197	CcSEcCtD
Enzalutamide—Headache—Prednisone—psoriatic arthritis	0.000203	0.00186	CcSEcCtD
Enzalutamide—Asthenia—Methotrexate—psoriatic arthritis	0.000194	0.00178	CcSEcCtD
Enzalutamide—Pruritus—Methotrexate—psoriatic arthritis	0.000191	0.00176	CcSEcCtD
Enzalutamide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000185	0.0017	CcSEcCtD
Enzalutamide—Dizziness—Methotrexate—psoriatic arthritis	0.000179	0.00164	CcSEcCtD
Enzalutamide—Headache—Methotrexate—psoriatic arthritis	0.000169	0.00156	CcSEcCtD
